Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

NCT00931957 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Behcet Syndrome
Uveal Disease

Interventions

DRUG: Etanercept, Methotrexate, Prednisolone

Sponsor

Tehran University of Medical Sciences

Collaborators

[object Object]